文献速递垂体与肾上腺疾病

开发预测评分以避免疑似原发性醛固酮增多症患者的确认试验

Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究基于1024例接受确认试验的原发性醛固酮增多症(PA)疑似患者,利用机器学习与回归分析开发诊断模型及16分PACT评分,在训练队列(n=522)和内部(n=174)及外部(n=328)验证队列中评估。PACT评分分类正确率分别为84.1%、83.9%和81.1%,应用流程图可减少22.8%的确认试验。

要点

  • PACT评分可正确分类约84%的PA疑似患者,外部验证正确率81.1%。
  • 使用PACT评分流程图选择患者进行确认试验,可减少22.8%的确认试验数量。
  • 男性、降压药、血浆肾素活性、醛固酮、钾水平及靶器官损害与PA确诊相关。

核心结论

  • 将诊断建模算法整合到临床实践可能通过避免不必要的确认试验来改善PA患者的管理。

研究设计与样本

  • 评估1024例接受PA确认试验的患者,诊断模型在训练队列(n=522)中开发,并在内部验证队列(n=174)和独立外部前瞻性队列(n=328)中测试。
  • 通过机器学习和回归分析开发不同诊断模型及一个16分评分,以区分确诊PA的患者。

主要发现

  • 男性、降压药使用、血浆肾素活性、醛固酮、钾水平及靶器官损害的存在与PA确诊相关。
  • 基于机器学习的模型准确度为72.9%-83.9%。
  • PACT评分在训练队列中正确分类84.1%,内部验证83.9%,外部验证81.1%。
  • 采用PACT评分的流程图正确管理所有患者,并使确认试验数量减少22.8%。

关键数值与推荐

  • PACT评分为16分评分,基于男性、降压药、血浆肾素活性、醛固酮、钾水平及靶器官损害等变量。

临床怎么用

  • 对于筛查阳性的疑似PA患者,可考虑使用PACT评分流程图选择需进行确认试验的患者,以减少不必要的确认试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The diagnostic work-up of primary aldosteronism (PA) includes screening and confirmation steps. Case confirmation is time-consuming, expensive, and there is no consensus on tests and thresholds to be used. Diagnostic algorithms to avoid confirmatory testing may be useful for the management of patients with PA. OBJECTIVE: Development and validation of diagnostic models to confirm or exclude PA diagnosis in patients with a positive screening test. DESIGN, PATIENTS, AND SETTING: We evaluated 1024 patients who underwent confirmatory testing for PA. The diagnostic models were developed in a training cohort (n = 522), and then tested on an internal validation cohort (n = 174) and on an independent external prospective cohort (n = 328). MAIN OUTCOME MEASURE: Different diagnostic models and a 16-point score were developed by machine learning and regression analysis to discriminate patients with a confirmed diagnosis of PA. RESULTS: Male sex, antihypertensive medication, plasma renin activity, aldosterone, potassium levels, and the presence of organ damage were associated with a confirmed diagnosis of PA. Machine learning-based models displayed an accuracy of 72.9%-83.9%. The Primary Aldosteronism Confirmatory Testing (PACT) score correctly classified 84.1% at training and 83.9% or 81.1% at internal and external validation, respectively. A flow chart employing the PACT score to select patients for confirmatory testing correctly managed all patients and resulted in a 22.8% reduction in the number of confirmatory tests. CONCLUSIONS: The integration of diagnostic modeling algorithms in clinical practice may improve the management of patients with PA by circumventing unnecessary confirmatory testing.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Burrello J, Amongero M, Buffolo F, et al. Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism. J Clin Endocrinol Metab. 2021. PMID: 33377974. doi:10.1210/clinem/dgaa974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。